Skip to content

Joint Replacement or Interpositional Arthroplasty for CMC1 Arthritis, a Prospective Trial

Total Joint Replacement or Interpositional Arthroplasty for the Treatment of Arthritis in the Carpometacarpal Joint of the Thumb

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02556515
Enrollment
40
Registered
2015-09-22
Start date
2008-11-24
Completion date
2018-03-16
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Keywords

CMC1, arthritis, degenerative arthritis, thumb, interpositional arthroplasty, total joint replacement

Brief summary

Interpositional arthroplasty is by many considered to be the current gold standard for the treatment of thumb carpometacarpal arthritis. The results are generally good, but the rehabilitation time can be long and failures are difficult to treat. Total joint replacements now exist with modern uncemented designs that can be an alternative treatment. Short term studies show that thumb function often is better and rehabilitation time shorter, however there is uncertainty with regards to the longevity of the implants. Currently no prospective randomized trials have compared these two treatment options. Our hypothesis is that the total joint replacement will give the same results or better when compared to the interpositional arthroplasty.

Detailed description

Eligible: patients \>18 years with pain and dysfunction from the first cmc joint. Clinical and radiological arthritis. Exclusion: degenerative changes in the STT joint (all patients are assessed by CT), other injuries in the hand/thumb, pregnancy Outcome measures: quick-Dash, Nelson hospital score, range of motion, grip strength Complications are registered. The patients are observed for two years and the investigators aim to include a total of 40 patients.

Interventions

PROCEDUREInterpositional arthroplasty (Burton-Pellegrini procedure)

Burton-Pellegrini procedure

PROCEDURETotal joint replacement

Total joint replacement

DEVICEElektra prosthesis

Elektra prosthesis

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* CMC 1 arthritis * Pain and dysfunction * Adult patients * General good health

Exclusion criteria

* Pregnancy * STT arthritis (CT scan preoperatively for all patients) * Other injuries in thumb/hand

Design outcomes

Primary

MeasureTime frameDescription
quick-DASHBaseline (preoperatively), and change from baseline postoperatively at 6 weeks, 3, 6, 12 and 24 months.two-page questionnaire with VAS-scale for pain and function.

Secondary

MeasureTime frameDescription
Nelson hospital scoreBaseline (preoperatively) and change from base line postoperatively at 6 weeks, 3, 6, 12 and 24 months.one page thumb-specific questionnaire first published In Journal of Hand Surgery (Eur) 2007, 32E: 5: 524-528

Other

MeasureTime frameDescription
Grip strengthbaseline (preoperatively) and change from base line postoperatively at 6 weeks, 3, 6, 12 and 24monthsGrip strength, key grip, tip-pinch measured by Jamar dynameter at each follow up
range of motionbaseline (preoperatively) and change from base line postoperatively at 6 weeks, 3, 6, 12 and 24 monthsRange of motion measured clinically (Kapandji opposition) and by x-ray (abduction, adduction, extension and flexion) at follow-up
complicationsregistered at 2 and 6 weeks. Thereafter at 3,6, 12 and 24 months.complications to either treatment form will be registered and published

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026